Drug Trial Radar · NCT03450629
Evaluation of Safety and Efficacy of PDP-716
Last checked: Nov 19, 2026Latest source record: Feb 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
682
Actual
Start
Sep 13, 2018
Primary completion
Dec 1, 2020
Study completion Dec 1, 2020
Sponsor
- Lead sponsor
- Sun Pharma Advanced Research Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will be conducted to evaluate the efficacy and safety of topical administration of PDP-716 compared with brimonidine tartrate ophthalmic solution.
Conditions
- Open Angle Glaucoma
- Ocular Hypertension
Interventions
Brimonidine Tartrate Ophthalmic SuspensionDrug
PDP-716
Brimonidine Tartrate Ophthalmic SolutionDrug
Three Times Brimonidine Tartrate Ophthalmic Solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Intraocular PressureTime frame: Week 12 8 AM, 10 AM and 4 PM
Locations
47 sites in 1 country. Site status is shown where the registry gives one.
SPARC Site 4
Chandler, Arizona
SPARC Site 5
Prescott, Arizona
SPARC Site 3
Sun City, Arizona
SPARC Site 38
Burbank, California
SPARC Site 44
Glendale, California
SPARC Site 45
Glendale, California
SPARC Site 43
Mission Hills, California
SPARC Site 1
Newport Beach, California
SPARC Site 14
Santa Barbara, California
SPARC Site 47
Torrance, California
SPARC Site 7
Colorado Springs, Colorado
SPARC Site 11
Coral Springs, Florida
SPARC Site 29
Deerfield Beach, Florida
SPARC Site 34
Fort Myers, Florida
SPARC Site 46
Hollywood, Florida
SPARC Site 21
Jacksonville, Florida
SPARC Site 35
Miami, Florida
SPARC Site 27
Miami, Florida
SPARC Site 10
Miami, Florida
SPARC Site 16
Miami, Florida
SPARC Site 19
Miami, Florida
SPARC Site 25
Miami, Florida
SPARC Site 41
Pompano Beach, Florida
SPARC Site 18
Tampa, Florida
SPARC Site 42
Atlanta, Georgia
SPARC Site 2
Morrow, Georgia
SPARC Site 22
Roswell, Georgia
SPARC Site 12
Chicago, Illinois
SPARC Site 23
Paducah, Kentucky
SPARC Site 40
Bowie, Maryland
SPARC Site 28
Kansas City, Missouri
SPARC Site 48
Kansas City, Missouri
SPARC Site 31
St Louis, Missouri
SPARC Site 15
Poughkeepsie, New York
SPARC Site 36
Rochester, New York
SPARC Site 30
Gastonia, North Carolina
SPARC Site 9
High Point, North Carolina
SPARC Site 17
Winston-Salem, North Carolina
SPARC Site 33
Fargo, North Dakota
SPARC Site 37
Cincinnati, Ohio
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.